January 2025 MHRA Safety Update
The MHRA has published a summary of letters and notifications issued to healthcare professionals during January 2025 concerning medicines and medical devices. This update consolidates recent safety communications to help you stay informed of regulatory actions affecting clinical practice.
What You Need to Know
This alert covers a range of regulatory actions taken by the MHRA in response to safety concerns, quality issues, and product recalls identified during January. The notifications are directed at healthcare professionals, including prescribers, dispensers, and clinical teams across primary and secondary care.
Recommended Actions
- Review the full MHRA alert to identify any products relevant to your clinical setting
- Check whether any affected medicines or devices are currently in use in your organisation
- Ensure your team is aware of any recall or safety actions affecting stock or patient care
- Follow specific guidance provided by the MHRA for each affected product
- Report any adverse events or quality concerns to the MHRA Yellow Card scheme
Further Information
For the complete list of affected medicines, medical devices, and detailed safety guidance, visit the MHRA’s official alert page.
Stay updated with all MHRA safety communications via First Responder to ensure your practice remains compliant and your patients receive safe care.